The University of Alabama at Birmingham will launch the first Phase 1 human trials of a drug—derived from the female hormone estrogen—that may help patients with severe bleeding survive long enough to get to appropriate medical care.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.